Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920685's Forward Dividend Yield % is ranked worse than 72.2% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs BJSE:920685: 1.07
Ningbo Scientz Biotechnology Co (BJSE:920685) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Ningbo Scientz Biotechnology Co Forward Dividend Yield % Related Terms
BJSE:920685 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Ningbo Scientz Biotechnology Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningbo Scientz Biotechnology Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ningbo Scientz Biotechnology Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Ningbo Scientz Biotechnology Co's Forward Dividend Yield % falls into.
Ningbo Scientz Biotechnology Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Ningbo Scientz Biotechnology Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.130000
2026-06-09
2026-06-08
2026-06-09
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.07% mean?
Ningbo Scientz Biotechnology Co (BJSE:920685) has a Forward Dividend Yield % of 1.07% as of Aug. 17, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Ningbo Scientz Biotechnology Co and its competitors. According to the industry distribution chart, Ningbo Scientz Biotechnology Co ranks #226 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Ningbo Scientz Biotechnology Co's Forward Dividend Yield % too high?
Ningbo Scientz Biotechnology Co's current Forward Dividend Yield % is 1.07%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.04. Ningbo Scientz Biotechnology Co's value of 1.07% is 47.5% below this industry median. Based on the distribution chart, Ningbo Scientz Biotechnology Co ranks #226 out of 313 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ningbo Scientz Biotechnology Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningbo Scientz Biotechnology Co's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ningbo Scientz Biotechnology Co ranks #226 out of 313 companies for Forward Dividend Yield %. This places Ningbo Scientz Biotechnology Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.04. Ningbo Scientz Biotechnology Co's value of 1.07% is 47.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.04, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningbo Scientz Biotechnology Co's current Forward Dividend Yield % of 1.07% is 47.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Ningbo Scientz Biotechnology Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningbo Scientz Biotechnology Co's current Forward Dividend Yield % is 1.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbo Scientz Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbo Scientz Biotechnology Co (BJSE:920685) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.96, compared to a current price of ¥12.18 — trading 23.7% below its estimated fair value. The current Forward Dividend Yield % is 1.07% and 47.5% below the Medical Devices & Instruments industry median of 2.04. Ningbo Scientz Biotechnology Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Ningbo Scientz Biotechnology Co (BJSE:920685), the current Forward Dividend Yield % is 1.07% as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningbo Scientz Biotechnology Co (BJSE:920685) Overvalued in 2026?
Based on GuruFocus' analysis, Ningbo Scientz Biotechnology Co stock appears to be undervalued.
The current stock price of ¥12.18 is trading 23.7% below its estimated GF Value™ of ¥15.96.
GuruFocus considers Ningbo Scientz Biotechnology Co to be Modestly Undervalued.
Key valuation signals for BJSE:920685:
Forward Dividend Yield %: 1.07%
GF Value™: ¥15.96 vs. price of ¥12.18 (23.7% below fair value)
Industry Position: 47.5% below the Medical Devices & Instruments median (#226 of 313)
No single metric tells the full story. See the BJSE:920685 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920685 has been successfully added to your 
